Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 : a randomised, double-blind, placebo-controlled, phase 1 trial / Keith J Chappell [and twenty four others]
Subject(s):
Hello from Record Display Customizations!
| Cover image | Item type | Current library | Home library | Collection | Shelving location | Call number | Materials specified | Vol info | URL | Copy number | Status | Notes | Date due | Barcode | Item holds | Item hold queue priority | Course reserves | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Journal Article
|
DOH Central Library Electronic Resource Section | COVID-19-000195 (Browse shelf(Opens below)) | Available | D0001C000195 |
Browsing DOH Central Library shelves,Shelving location: Electronic Resource Section Close shelf browser (Hides shelf browser)
Lancet Infect Dis . 2021 Apr 19;S1473-3099 (21) 00200-0.
doi: 10.1016/S1473-3099(21)00200-0.
There are no comments on this title.
Log in to your account to post a comment.